Fatty liver study pulled before it began: new imaging test never tested
NCT ID NCT05827432
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study was designed to see if a special MRI technique called field-cycling imaging could tell the difference between simple fatty liver and more serious liver scarring (fibrosis) in adults with non-alcoholic fatty liver disease (NAFLD). The goal was to find a non-invasive way to track disease progression without a biopsy. However, the study was withdrawn before any participants were enrolled, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aberdeen Royal Infirmary
Aberdeen, AB25 2ZN, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a scan replace the needle? ultrasound and MRI put to the test against liver biopsy for fatty liver disease
- Can fish oil shrink a fatty liver?
- Could donating blood help control diabetes and fatty liver?
- Could a diabetes drug reverse liver scarring?
- Blood test and AI could spot liver cancer early, saving lives
- New blood test may sharpen diagnosis of autoimmune liver disease